Sky Century Investment (SKYI) EBITDA Margin (2024 - 2026)
Sky Century Investment (SKYI) posted quarterly EBITDA Margin of 11.34% for Q2 2026, up 3097.0% year-over-year from 0.35% in Q2 2025, and down 183.07% quarter-over-quarter from 13.65% in Q1 2026.
Sky Century Investment (SKYI) EBITDA Margin (2024 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has reported EBITDA Margin for 3 consecutive years, with 11.34% the latest figure, recorded in Q2 2026.
- In Q2 2026, EBITDA Margin rose 3097.0% year-over-year to 11.34%; the TTM figure through May 2026 stood at 49.48% (up 8767.0% YoY), while the FY2025 annual figure was 152.78%, down 1201.0% from the prior year.
- EBITDA Margin retreated to 11.34% in Q2 2026 per SKYI's latest filing, from 13.65% in the prior quarter.
- Across five years, EBITDA Margin topped out at 13.65% in Q1 2026 and bottomed at 256.47% in Q1 2024.
- Historically, EBITDA Margin has averaged 103.82% across 3 years, with a median of 78.17% in 2025.
- Annual changes were most pronounced in 2025 — EBITDA Margin plunged 9761 bps — and 2026, when it soared 20275 bps.
- Sky Century Investment's EBITDA Margin stood at 16.42% in 2024, then plunged by 1207 bps to 214.51% in 2025, then surged by 95 bps to 11.34% in 2026.
- Business Quant data shows SKYI's EBITDA Margin at 11.34% in Q2 2026, 13.65% in Q1 2026, and 214.51% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Sky Century Investment | 393,547.71 | 393,283.71 | 26,045.00 | -11.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -11.34% |
| Feb 28, 2026 | 13.65% |
| Nov 30, 2025 | -214.51% |
| Aug 31, 2025 | -114.03% |
| May 31, 2025 | -42.31% |
| Feb 28, 2025 | -189.11% |
| Aug 31, 2024 | -16.42% |
| Feb 29, 2024 | -256.47% |